Genes Identified That Increase Children's Risk Of Blood Infection
By LabMedica International staff writers Posted on 16 Jun 2016 |
Image: The MassARRAY system for iPlex single nucleotide polymorphism (SNP) genotyping (Photo courtesy of Sequenom).
Bacteremia is a bacterial infection of the bloodstream, and a major cause of illness and death in sub-Saharan Africa but little is known about whether human genetics play a part.
The leading bacterial cause of death in young children worldwide is Streptococcus pneumoniae or pneumococcus and 14.5 million episodes of serious pneumococcal disease occur in young children annually. Genes have been identified that make certain children more susceptible to invasive bacterial infections.
A global network of scientists coordinated from the Wellcome Trust Centre for Human Genetics (Oxford, UK), carried out a genome-wide association study to identify which genes might be associated with an increased likelihood of developing bacteremia. The study looked at DNA samples from more than 4,500 Kenyan children from the Kilifi area where there is a high occurrence of bacteremia. Just over 4,000 children were healthy, while slightly more than 500 had pneumococcal bacteremia.
Genomic DNA was extracted using the QIAamp DNA blood mini kit (QIAGEN, Hilden, Germany) and whole-genome amplified samples from case and control subjects were genotyped on the genome-wide Affymetrix SNP 6.0 chip (Affymetrix Inc, Santa Clara, CA, USA). Single nucleotide polymorphisms (SNP) in the additive or the genotypic model were directly genotyped in the discovery set to confirm imputation accuracy and in the replication sample set to confirm the associations using two iPLEX assays (Sequenom, San Diego, CA, USA). To quantify levels of long intergenic non-coding ribonucleic acid (RNA) expression, the teams performed quantitative real-time polymerase chain reaction (qPCR) using a relative quantification method.
The study found an area of two long intergenic noncoding RNA (lincRNA) genes that was associated with susceptibility to pneumococcal bacteremia. LincRNAs are RNA transcripts that are longer than 200 nucleotides but are not translated into proteins. LincRNAs are still little understood, although it is believed that the human genome has more than 10,000 of them.
Anna Rautanen, PhD, a senior author of the study, said, “'One of the associated lincRNA genes, called AC011288.2, is expressed only in neutrophils, cells that are known to have a key role in clearing pneumococcal disease. Critically, the genetic variants we have identified carry a doubled risk of developing bacteremia when infected with the Streptococcus pneumoniae bacteria. This discovery therefore provides clues in the pressing search for new ways to target the disease.” The study was published on June 2, 2016, in the American Journal of Human Genetics.
Related Links:
Wellcome Trust Centre for Human Genetics
QIAGEN
Affymetrix
Sequenom
The leading bacterial cause of death in young children worldwide is Streptococcus pneumoniae or pneumococcus and 14.5 million episodes of serious pneumococcal disease occur in young children annually. Genes have been identified that make certain children more susceptible to invasive bacterial infections.
A global network of scientists coordinated from the Wellcome Trust Centre for Human Genetics (Oxford, UK), carried out a genome-wide association study to identify which genes might be associated with an increased likelihood of developing bacteremia. The study looked at DNA samples from more than 4,500 Kenyan children from the Kilifi area where there is a high occurrence of bacteremia. Just over 4,000 children were healthy, while slightly more than 500 had pneumococcal bacteremia.
Genomic DNA was extracted using the QIAamp DNA blood mini kit (QIAGEN, Hilden, Germany) and whole-genome amplified samples from case and control subjects were genotyped on the genome-wide Affymetrix SNP 6.0 chip (Affymetrix Inc, Santa Clara, CA, USA). Single nucleotide polymorphisms (SNP) in the additive or the genotypic model were directly genotyped in the discovery set to confirm imputation accuracy and in the replication sample set to confirm the associations using two iPLEX assays (Sequenom, San Diego, CA, USA). To quantify levels of long intergenic non-coding ribonucleic acid (RNA) expression, the teams performed quantitative real-time polymerase chain reaction (qPCR) using a relative quantification method.
The study found an area of two long intergenic noncoding RNA (lincRNA) genes that was associated with susceptibility to pneumococcal bacteremia. LincRNAs are RNA transcripts that are longer than 200 nucleotides but are not translated into proteins. LincRNAs are still little understood, although it is believed that the human genome has more than 10,000 of them.
Anna Rautanen, PhD, a senior author of the study, said, “'One of the associated lincRNA genes, called AC011288.2, is expressed only in neutrophils, cells that are known to have a key role in clearing pneumococcal disease. Critically, the genetic variants we have identified carry a doubled risk of developing bacteremia when infected with the Streptococcus pneumoniae bacteria. This discovery therefore provides clues in the pressing search for new ways to target the disease.” The study was published on June 2, 2016, in the American Journal of Human Genetics.
Related Links:
Wellcome Trust Centre for Human Genetics
QIAGEN
Affymetrix
Sequenom
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans